Protocolized Sedative Weaning VS. Usual Care in Pediatric Critically Ill, RCT

Sponsor
Ramathibodi Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03018977
Collaborator
(none)
60
1
2
14.9
4

Study Details

Study Description

Brief Summary

Sedative and analgesic agents are widely used in the ICU. These agents can provide hypnotic effect, pain alleviation, cooperation, and synchronizing ventilatory support. Prolonged use of the agents can lead to withdrawal symptoms when the drugs are weaned.

Prior study showed the longer duration of sedative drugs, cumulative dose of medications and younger age were the risk factors of withdrawal syndrome. Additional, some study showed the sedation protocol can reduce the incidence of withdrawal syndrome. However, no worldwide standardized sedative weaning protocol including our hospital. The objectives in this study are to establish the sedative weaning protocol and to compare the protocol sedative weaning with the usual care weaning.

Condition or Disease Intervention/Treatment Phase
  • Other: The sedative weaning protocol group
  • Other: The usual group
N/A

Detailed Description

Sedative and analgesic agents, particularly benzodiazepines and opioids, are widely used in PICU. These agents can provide calmness, hypnotic effect, pain alleviation, cooperation, immobilization and synchronizing ventilatory support.

Prolonged use of the agents can lead to withdrawal symptoms when the drugs are weaned.

Incidence of withdrawal syndrome is about 50%. Withdrawal syndrome can lead to unnecessary and costly diagnostic tests, prolongation of mechanical ventilation and hospital stay, and increasing of suffering. Prior study showed the longer duration of sedative drugs, cumulative dose of medications and younger age were the risk factors of withdrawal syndrome. Additional, some study showed the sedation protocol can reduce the incidence of withdrawal syndrome. However, no worldwide standardized sedative weaning protocol including our hospital.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Protocolized Sedative Weaning Versus Usual Care in Pediatric Critically Ill, Randomized Controlled Trial
Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Mar 1, 2018
Actual Study Completion Date :
Apr 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Sedative weaning protocol

We create the new sedative weaning protocol and then use the sedative weaning protocol.

Other: The sedative weaning protocol group
After physician decide to wean sedative or analgesic drugs. We divided to 2 groups including high risk group and low risk group. The sedative weaning protocol were used in these patients which rely on the high risk or low risk group.

Placebo Comparator: Usual Care

no use sedative weaning protocol. Sedative or/and analgesic medications are adjusted base on physician

Other: The usual group
After physician decide to wean sedative or analgesic drugs. The sedative/analgesic drugs were weaned depend on physician

Outcome Measures

Primary Outcome Measures

  1. incidence of withdrawal symptom [72 hour]

Secondary Outcome Measures

  1. length of PICU stay [30 days]

  2. sedation related adverse events [7 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Month to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients aged 1 mo to 18 yrs, at least 37 week of postmenstrual age

  • Patient who was admitted in PICU or intermediate ward at Ramathibodi hospital

  • use analgesic/sedative drugs (parenteral)≥ 3 days

Exclusion Criteria:
  • Patients in whom level of sedation or withdrawal assessment cannot be scored.

  • Patients transferred from other hospitals in which the patients have already presented of withdrawal symptoms

  • patient/parent refuse this study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Pediatric,Ramathibodi Hospital Bangkok Thailand 10400

Sponsors and Collaborators

  • Ramathibodi Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nattachai Anantasit, Assistant Professor, Ramathibodi Hospital
ClinicalTrials.gov Identifier:
NCT03018977
Other Study ID Numbers:
  • ID125808
First Posted:
Jan 12, 2017
Last Update Posted:
Apr 11, 2018
Last Verified:
Apr 1, 2017
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 11, 2018